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Dilated cardiomyopathyCells that constitute fully differentiated tissues are characterised by an architecture that makes them perfectly
suited for the job they have to do. This is especially obvious for cardiomyocytes, which have an extremely regular
shape and display a paracrystalline arrangement of their cytoplasmic components. This article will focus on the
two major cytoskeletal multiprotein complexes that are found in cardiomyocytes, the myoﬁbrils, which are re-
sponsible for contraction and the intercalated disc, which mediates mechanical and electrochemical contact be-
tween individual cardiomyocytes.
Recent studies have revealed that these two sites are also crucial in sensing excessivemechanical strain. Signalling
processes will be triggered that## lead to changes in gene expression and eventually lead to an altered cardiac
cytoarchitecture in the diseased heart,which results in a compromised function. Thus, understanding these chang-
es and the signals that lead to them is crucial to design treatment strategies that can attenuate these processes. This
article is part of a Special Issue entitled: Cardiomyocyte Biology: Integration of Developmental and Environmental
Cues in the Heart edited by Marcus Schaub and Hughes Abriel.
© 2016 The Author. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Cells that make up fully differentiated tissues are characterised by a
shape and subcellular organisation that enables them to carry out which-
ever task they have to perform. In case of the cells that make up the con-
tractile tissue of the heart, the cardiomyocytes, this high degree of
organisation is already apparent at the light microscopy level by a more
or less rectangular shape of the isolated cells and a cross-striated appear-
ance in phase contrast, which is due to the paracrystalline arrangement of
the contractile elements, themyoﬁbrils. This amazing degree of organisa-
tion is not only seen at the level of the cardiomyocyte itself, but also how
they are combined to a tissue [1]. On longitudinal sections through
healthy heart tissue, cell–cell contacts are exclusively found at the narrow
ends of the bipolar cardiomyocytes, hence their name intercalated discs,
while cell–matrix contacts ensheath the cells laterally (Fig. 1). This orga-
nisation is crucial for the directedpropagationof electrical signals through
serial strands of cardiomyocytes. In disease, this strict order is compro-
mised, ultimately leading to arrhythmias that can even cause sudden car-
diac death. This high degree of organisation is also a major obstacle for
any attempts to regenerate damaged heart tissue for example after a
myocardial infarction. No matter, which replacement strategy is consid-
ered (re-activation of cell division of endogenous cardiomyocytes;yocyte Biology: Integration of
edited by Marcus Schaub and
Biophysics, New Hunt's House,
. This is an open access article underinjection of contractile cells; transplantation of cardiomyocytes in scaf-
folds or in patches), if there is no directed electrochemical contact and
controlled mechanical integration with the host tissue, life-threatening
arrhythmias are the likely consequence [2]. This review will focus on cy-
toskeletal multiprotein complexes, which are at the basis of cardiac
cytoarchitecture, the myoﬁbrils and the intercalated discs (Fig. 1).
1. The myoﬁbrils
Themyoﬁbrils make up the contractilemachinery, inwhich the con-
tractile partners actin and myosin are arranged to interdigitating thin
and thick ﬁlaments in a way that ensures maximal force output. The
basic unit of a myoﬁbril is called the sarcomere and is deﬁned as the re-
gion between two Z-discs. The actin crosslinker protein α-actinin is a
classical marker for the Z-disc; however the Z-disc harbours a plethora
of other cytoskeletal and signalling proteins [3]. The Z-discs anchor
the thin ﬁlaments, which are composed of actin, tropomyosin and the
troponin complex. Tropomyosin and the troponin complex are crucial
for regulation of contraction at the thinﬁlament level, which is triggered
by calcium. The thin ﬁlaments are capped at their barbed ends in the Z-
disc by CapZ [4] and at their pointed ends, which stretch towards the
middle of the sarcomere by tropomodulin [5]; for recent reviews of
thin ﬁlament length control see Refs. [6,7]. The thick ﬁlaments are com-
posed of dimers of myosins (amyosin consists of onemyosin heavy and
two myosin light chains), which are arranged to bipolar ﬁlaments with
the myosin tails making up the central region of the sarcomere and thethe CC BY license (http://creativecommons.org/licenses/by/4.0/).
Fig. 1. Schematic drawing of a cardiomyocyte. The basic unit of themyoﬁbril, the sarcomere, the contacts between the cardiomyocyte and the extracellular matrix (ECM) and the contacts
between two neighbouring cardiomyocytes; the intercalated discs are shown in insets above the cell. Mitochondria are represented as mottled ovals. Sarcomere: Z-discs, the lateral bor-
ders of a sarcomere, are depicted in dark green and anchor the thin ﬁlaments (actin and associated proteins) shown in yellow. The thick ﬁlaments (myosin and associated proteins) are
shown in dark blue and are linkedwith the elastic ﬁlaments (titin; shown in red) at theM-band in themiddle of the sarcomere (shown in purple). Costamere: Themyoﬁbrils are linked to
the plasmamembrane at Z-disc level via the costameres (shownwith a pink triangle in the lower cell). Also at Z-disc level are speciﬁc membrane invaginations, the T-tubules, which as-
sociate with ﬂanking SR to the Dyad (shown in the upper cell). ECM is depicted in brown. Intercalated disc: Desmosomes (shown in green) and adherens junctions (AJ, shown in orange)
link neighbouring cardiomyocytes mechanically while gap junctions (GJ, shown in light blue) provide ion channels for intercellular communication. Desmosomes link up to the interme-
diate ﬁlament cytoskeleton (composed of desmin), while adherens junctions anchor actin ﬁlaments (the myoﬁbrils). The border of the last sarcomere before the plasma membrane is
deﬁned as the transitional junction (TrJ).
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(Myosin binding protein C; C-protein) is associated with a subset of
the myosin heads and contributes to the control of contraction at the
thickﬁlament level [8]. The third ﬁlament system is called the elastic ﬁl-
aments and is made up of titin (previously called connectin [9]). One
titin molecule stretches from the Z-disc, where its N-terminus is an-
chored to the M-band, where its C-terminus overlaps with titin
stretching from the other half of the sarcomere. Due to its position in
the sarcomere and the observation that cells lacking titin are unable to
assemble sarcomeres [10], titin has been attributed with an absolutely
crucial role duringmyoﬁbrillogenesis [11]. TheM-band is themolecular
structure that links elastic and thick ﬁlaments and is necessary to keep
thick ﬁlaments centred in the sarcomere. Its main marker protein
is myomesin, which gets localised together when the ﬁrst organised
A-bands are seen [12]. Thus M-bands are deﬁned molecularly by the
presence of myomesin rather than an electron dense appearance in
the electron microscope, which is only attained postnatally. Depending
on muscle type and developmental stage additional M-band proteins
such as M-protein, the splice variant of myomesin, EH-myomesin or
myomesin-3 are added to myomesin in the M-band [13].
2. Protein turnover in the sarcomere
The somewhat static arrangement of the sarcomere that is suggested
by the regular appearance of sarcomeres in electron micrographs, is
probably an oversimpliﬁcation. Changed physiological demands lead
to adaptations for example by switching the expression levels ofmyosin
heavy chain isoforms [14]. In addition, observations on the protein turn-
over of thin ﬁlament components have indicated a half-life between 3
and 10 days in the rat heart [15]. This would suggest that every 1 to 2
weeks, the molecular makeup of a sarcomere is exchanged. Sincethese measurements were carried out at the whole heart level, it is un-
clear, whether different heart regions display a different dynamics in
their protein turnover and how much this is affected for example by
the expression of mutant and/or aggregating proteins. As far as actin
turnover is concerned, it was revealed in recent studies that proteins,
which are well known to affect actin polymerisation such as N-WASP,
leiomodin or the formin family member FHOD3 are expressed in striat-
ed muscle and are located in the sarcomere either at the barbed (N-
WASP, FHOD3) or the pointed ends (leiomodin) of the thin ﬁlaments
[16–18]. Their position in the sarcomere and extent of expression is de-
pendent on the developmental stage or on physiological stress [19–21].
3. The intercalated disc
The intercalated discs ensure electrochemical and mechanical con-
nection between neighbouring cardiomyocytes and are situated at the
end of a cardiomyocyte [22]. According to the classical view they are
composed of three different types of cell–cell contacts: adherens junc-
tions, desmosomes and gap junctions. Adherens junctions anchor the
actin ﬁlaments (the myoﬁbrils) and are composed of N-cadherin as a
transmembrane component that provides the link to the neighbouring
cell and a cytoplasmic plaque that contains amongst others α-catenin
and β-catenin and connects to the actin ﬁlaments. The intercellular
link in desmosomes is provided by the desmosomal cadherins,
desmoglein and desmocollin, while the cytoplasmic plaque consists of
desmoplakin, plakophilin and plakoglobin, which link to the intermedi-
ate ﬁlament cytoskeleton, which is made up by desmin in muscle cells.
Gap junctions consist of connexin-43 in ventricular cardiomyocytes and
provide ion channels for intercellular communication (Fig. 1). This sim-
ple classiﬁcation has been challenged recently by observations that ﬁnd
classical desmosomal proteins such as desmoplakin, plakophilin and
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Therefore the terminology of “area composita” was introduced to de-
scribe plaque-bearing cell–cell contacts at the intercalated disc [23].
4. Lateral plasma membrane organisation
While the myoﬁbrils are anchored at their ends by the adherens
junctions, their sides are also attached to the plasma membrane at
regular intervals at the costameres, which are situated at the Z-disc
level [24]. A classical marker for costameres is vinculin [25] and they
provide via integrins the link to the extracellular matrix that covers
cardiomyocytes laterally (shown in brown in Fig. 1). In addition, there
are membrane invaginations at Z-disc level in cardiomyocytes, the T-
tubules, which are ﬂanked by sarcoplasmic reticulum (SR) and make
up the dyad structure, which is necessary for excitation contraction cou-
pling [26]. Cytoplasmic actins togetherwith a speciﬁc tropomodulin iso-
form play an important role in their organisation [27], together with the
protein Bin1, which is required for shaping T-tubules [28] and the pro-
tein junctophilin-2, which deﬁnes the distance between the plasma
membrane and the membrane of the SR [29]. Within the SR, proteins
such as triadin and to a lesser extent junctin [30,31] were shown to be
important for the organisation of diads in mice and recently mutations
in triadin were shown to be a possible cause of sudden cardiac death
in humans [32].
5. Establishment of cytoarchitecture during development
The regular cytoarchitecture described above is only attained after
birth in the heart.Whilemyoﬁbrils are assembled and contraction is ob-
served from embryonic day 9 onwards in mouse hearts, the myoﬁbrils
are still very thin and not well aligned laterally [33]. The Z-disc associat-
ed protein telethonin (also known as T-cap), which links two N-termini
of titin in a sandwich like complex [34], a structurewhich is required for
maximal stability of sarcomeres [35], is only expressed in a subset of
neonatal rat cardiomyocytes and also the switch inM-band composition
from amore immature statemarked by the presence of themore elastic
EH-myomesin isoform to themature state, which is characterised by the
incorporation of M-protein and the appearance of M1-lines at the EM
level, is only achievedpostnatally [36]. The sparser arrangement ofmyo-
ﬁbrils, less lateral crosslinking via desmin and the lack ofmaturity of the
sarcomeres makes them more pliable for disassembly, which is a
prerequisite for successful cell division of cardiomyocytes [37]. In the
embryonic heart, the cell–cell contacts are distributed over the entire
surface of the cardiomyocytes and become restricted concomitant
with a cellular elongation and better myoﬁbril alignment only around
birth [33]. Also the organisation of the plasmamembrane and the sarco-
plasmic reticulum to dyads is only achieved after birth [26].
In theﬁrst postnatalweek a switch fromhyperplastic (i.e. growth via
cell division) to hypertrophic (i.e. growth via increase in cell size) takes
place in the heart [38] and the ensuing increase in cellular girth and in-
creased organisation of their cytoarchitecture contributes tomaking cell
division a more unfavourable process. Elegant studies by Porrello and
colleagues have shown that neonatal mouse hearts still possess the
ability to regenerate by reactivation of cell division in cardiomyocytes
and that this ability gets lost within the ﬁrst week after birth [39]. Re-
cent studies have correlated a regenerative capacitywith a speciﬁc tran-
scriptional signature, which resembles a more immature phenotype
[40]. It was postulated that the trigger for the switch may be the
oxygen-rich environment after birth and a residual population of small-
er cardiomyocytes with hypoxic characteristics and increased prolifera-
tive potential was identiﬁed [41]. Zebraﬁsh cardiomyocytes retain their
proliferative capacity also at adult stages [42], but they are long and
slender and do not have dyads [43]. Cardiomyocyte division in the
adult would require the disassembly of the myoﬁbrils, the disassembly
of their sophisticated membrane organisation and the disintegration of
the separated cell–cell and cell–matrix contact arrangement and isclearly not trivial to achieve. This is probably the explanation, while a
lot of attempts to induce cell division in cardiomyocytes by the forced
expression of cell cycle regulating factors havemetwith limited success,
but also has the positive side effect that cancerous growth of
cardiomyocytes is extremely rare [44]. There are reports of cardiomyo-
cyte turnover to a varying degree in human heart [45,46] and it is also
well established that there are several populations of stem cell-like
properties in the mammalian heart [47–50]. However, under normal
circumstances these activities are insufﬁcient to deal with heart tissue
loss for example following a myocardial infarction. Challenges that
lead to pathological growth of cardiomyocytes result in additional
DNA synthesis and even the re-expression of cytokinesis markers in
cardiomyocytes [51], but signiﬁcant cell division activity can usually
not be observed. Recently it was demonstrated that a reluctance to di-
vide in adult mammalian cardiomyocytes can also be explained by a
loss of centrosome integrity immediately after birth, which does not
happen in zebraﬁsh cardiomyocytes [52]. Taken together all these so-
phistications that characterise postnatal mammalian cardiomyocytes
contribute to their inability to divide and make it a formidable task to
switch them back to a more immature, dividing state. It is unlikely
that a single magic molecular bullet will be sufﬁcient to achieve
this, but broader interference at an epigenetic level will probably be
required.
6. Why does cardiac cytoarchitecture matter?
As described above the high degree of organisation at the tissue and
cellular level in the heart is needed for maximal functional output with
every heart beat. A ﬁrst insight that even a point mutation in one of the
cytoskeletal proteins that make up this cytoarchitecture can have grave
consequences, was the discovery that a single amino acid change in the
myosin heavy chain molecule can be correlated with hereditary cardio-
myopathy, in this case familial hypertrophic cardiomyopathy [53]. It is
nowwell established that mutations in proteins that make up themyo-
ﬁbrils or the intercalated discs lead to hereditary cardiomyopathies
[54–57]. The majority of point or frameshift mutations in myoﬁbrillar
proteins lead to hypertrophic cardiomyopathy [54], while truncations
in titin were recently shown to account for a ﬁfth of hereditary dilated
cardiomyopathy [58]. Mutations in desmosomal proteins lead to ar-
rhythmogenic right ventricular cardiomyopathy and to sudden cardiac
death, potentially via an effect on connexin-43 in gap junctions [59,
60]. The list of cardiomyopathies clearly associated with mutations
will expand dramatically due to next generation sequencing in the
next years; however, it is interesting to bear in mind that despite muta-
tions in distinct proteins, the general histology observed in hypertrophic
cardiomyopathy (HCM) and dilated cardiomyopathy (DCM) seems to
be mutation independent.
HCM leads tomyocyte andmyoﬁbril disarray, which is clearly appar-
ent even at the histological level, while heart tissue from DCM patients
can look relatively unharmed apart fromobvious areas ofmyocyte drop-
out and ﬁbrosis. The changes in cardiac cytoarchitecture that are seen in
DCM are subtle and mainly affect the intercalated disc. The plasma
membrane between neighbouring cardiomyocytes gets more convolut-
ed, resembling cell–cell contacts from aged hearts [61]. This is accompa-
nied by a more disorganised insertion of novel sarcomeres at the
intercalated disc region in DCM [62]. In addition, an increase in actin an-
choring components and also of F-actin is detected [63]. Thismay in part
be due to the increased presence of a formin, FHOD1, at the intercalated
discs of DCM hearts [64]. However, not all formins are upregulated in
their expression in DCM, since FHOD3, which plays a role in myoﬁbril
maintenance in the embryo [65] and in cultured cardiomyocytes [17]
was seen to be downregulated in human cardiomyopathy, potentially
contributing to myoﬁbril loss. Another change that is seen in DCM
cardiomyocytes is the switch to more elastic isoforms of titin and
myomesin in the myoﬁbrils [66,67]. Cardiac cytoarchitecture is also af-
fected as far as integration to a tissue is concerned, since for example
Fig. 2. Confocal micrographs of human heart tissue immunostained for the intercalated discs and themyoﬁbrils. Longitudinal cryosections of human heart tissue from a control individual
(male, 23 years) and a dilated cardiomyopathy (DCM) patient (male, 31 years) were stainedwithmousemonoclonal antibodies against β-catenin (red signal andmiddle row) and rabbit
polyclonal antibodies againstMyBP-C (green signal and bottom row). Nuclei were stainedwith DAPI and are shown in blue.While overall tissue arrangement andmyoﬁbril alignment are
relatively unaffected in DCM, an increased signal for β-catenin compared to control can be observed at the intercalated discs (arrows) and also laterally (arrowheads) in DCM. Scale bar is
10 μm.
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is lost and for example adherens junction proteins such asβ-catenin can
also be detected at the sides of cardiomyocytes, especially in HCM [68]
but also occasionally in DCM (Fig. 2). The expression of connexin-43 is
dowregulated in murine DCM and thus there are fewer gap junctions
available to mediate intercellular communications [63]. This phenotype
is less penetrant in human DCM samples [69], but a mislocalisation
of connexins was also described in HCM and following myocardial
infarction [70]. Also the lateral membrane organisation gets lost inFig. 3. Schematic representation of signalling events in dilated cardiomyopathy (DCM). The two
M-band region of the sarcomeres (3). Several signalling cascades (2, 4) lead to altered gene e
(upregulation of actin-anchoring proteins) and the sarcomeres (re-expression of more elastic
as an altered shape, loss of strict size control and loss of high degree of plasma membrane orgcardiomyopathy, with T-tubules and dyads becoming less organised
and costameres as visualised by vinculin losing their regular striated ap-
pearance [28,63,71–73].
It has been shown that mutations in myosin, tropomyosin and titin
can result in different phenotypes such as HCM, DCM and even arrhyth-
mogenic right ventricular cardiomyopathy (ARVC) and the correlation
between a mutation in a particular protein and the disease phenotype
is obviously not as clear-cut as initially proposed [74]. The histological
and molecular analysis of human material is usually restricted tomajor sensors ofmechanical stress are the intercalated discs (1) and the Z-disc, I-band and
xpression (5), which eventually results in a different composition of the intercalated disc
embryonic isoforms of titin and myomesin) and changes in overall cytoarchitecture such
anisation (6). Mitochondria are represented as mottled ovals.
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the aetiology of cardiomyopathy, a more ﬂuid interchange between
phenotypes may be seen that can only be followed in animal models
for cardiomyopathy. A particular mutation will affect protein–protein
interactions, activity, subcellular targeting or stability of a particular
molecule, but the phenotype is caused by the impairment at the cellular
level and any compensatory mechanisms (e.g. posttranscriptional con-
trol of expression; different protein turnover) that were activated.7. What leads to an altered cardiac cytoarchitecture
in cardiomyopathy?
The myoﬁbrils and the intercalated discs are not only essential for
the function of the heart tissue, but are also centres formechanosensing
and signalling (Fig. 3) [75]. For example the Z-disc harbours not only
structural proteins such as α-actinin but also kinases (PKCepsilon)
and phosphatases (calcineurin) that are well known to be involved in
signalling processes in cardiomyocytes [3]. Some cytoskeletal proteins
also contain PDZ domains, which act to establish proximity to plasma
membranes since lipids are needed for the activation of small GTPases
and kinases such as PKCα [76,77]. Cytoskeletal proteins often also con-
tain SH3 domains or LIM domains, which provide hubs for protein–pro-
tein interaction [78,79]. For example FHL1, which is a LIM domain
containing protein that associates with titin's I-band region is involved
in mediating signalling via ERK to the nucleus to trigger a hypertrophic
response [80,81]. Another mechansosensitive protein in the I-band is
CARP, which can trigger signalling, but can also translocate to the nucle-
us itself [82]. MLP (muscle LIM protein) can also switch its localisation
from the cytoplasm to thenucleus, dependingon themechanical stretch
that a cardiomyocyte experiences [83]. While the Z-discs deal mainly
with transversal forces during active contraction and are hardly affected
in their longitudinal arrangement, the M-bands (together with titin)
were shown to be crucial for dealing with longitudinal forces and with
centering the A-bands following contraction [84]. Interestingly, titin
harbours a kinase domain in its M-band region, whose active site be-
comes accessible upon mechanical stretch [85]. Whether this results
in actual kinase activity or opens up protein–protein interaction sites
that subsequently trigger a signalling cascade towards the nucleus is
under debate at the moment [86,87], but the involvement of MURF2
(amuscle speciﬁc E3 ubiquitin ligase), p62 (known to be involved in au-
tophagy) and SRF (a transcription factor with a well-established role in
the heart) suggests a fundamental role at different levels.
The redistribution of signalling components that accompanies car-
diomyopathy also contributes to changes in the downstream readout.
For example, the loss of lateral membrane organisation in failing hearts
leads to β2-adrenergic receptors no longer being concentrated at
T-tubules but being distributed more homogenously over the cell sur-
face, with a concomitant loss of tightly localised downstream signalling
[73]. Re-organisation of the intercalated discs in DCM is accompanied by
a concentration of PKCα there [88], which is known to contribute to
pathological signalling [89]. Recently it was shown that cardiomyocytes
differentiated from iPS cells from patients with titin truncations show
an impaired signalling via ERK, p38 and AKT pathways [90], again
linking malfunctional sarcomeres with altered signalling.
Exactly how the alterations in signalling that are seen in cardiomy-
opathy lead to the observed changes in cytoarchitecture is not well un-
derstood. It was shown that changes that affect alternative splicing can
be correlated with cardiomyopathy [91]. Mutation in the splicing asso-
ciated RNA-binding protein Rbm20 are found in DCM patients and
could result in alternative splicing of titin and myomesin [92]. Factors
that control transcription at the epigenetic level such as miRNAs and
lncRNAs are exciting candidates to cause the more pleiotropic changes
that are seen in cardiomyopathy [93–95] and may turn out to be an el-
egant tool to interfere withmaladaptive signalling processes that result
in altered cardiac cytoarchitecture.Acknowledgements
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